-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Upgrades Tandem Diabetes Care to Neutral, Raises Price Target to $10.35

Benzinga·08/12/2025 10:39:19
Listen to the news
Citigroup analyst Joanne Wuensch upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Sell to Neutral and raises the price target from $10 to $10.35.